RYR2 and catecholaminergic polymorphic ventricular tachycardia: In support of this idea, the mutation of GOF CaM-M37Q and the reinforcement of the CaM-RyR2 interaction have been demonstrated to be able to suppress the spontaneous release of Ca2+ from the SR and catecholaminergic polymorphic ventricular tachycardia [57].